Q4 2019 13F Holders as of 12/31/2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
8.56M
-
Number of holders
-
110
-
Total 13F shares, excl. options
-
58.2M
-
Shares change
-
+2.14M
-
Total reported value, excl. options
-
$958M
-
Value change
-
+$38.7M
-
Put/Call ratio
-
2.38
-
Number of buys
-
61
-
Number of sells
-
-40
-
Price
-
$16.47
Significant Holders of Atara Biotherapeutics, Inc. - Common Stock (ATRA) as of Q4 2019
131 filings reported holding ATRA - Atara Biotherapeutics, Inc. - Common Stock as of Q4 2019.
Atara Biotherapeutics, Inc. - Common Stock (ATRA) has 110 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 58.2M shares
.
Largest 10 shareholders include BAUPOST GROUP LLC/MA (8.31M shares), MAVERICK CAPITAL LTD (4.96M shares), Redmile Group, LLC (4.65M shares), BlackRock Inc. (4.58M shares), VANGUARD GROUP INC (3.68M shares), Camber Capital Management LP (2.95M shares), BRIDGER MANAGEMENT, LLC (2.93M shares), JPMORGAN CHASE & CO (2.67M shares), FEDERATED HERMES, INC. (2.28M shares), and STATE STREET CORP (2.2M shares).
This table shows the top 110 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.